Gu Hui-Wen, Wu Hai-Long, Yin Xiao-Li, Li Yong, Liu Ya-Juan, Xia Hui, Zhang Shu-Rong, Jin Yi-Feng, Sun Xiao-Dong, Yu Ru-Qin, Yang Peng-Yuan, Lu Hao-Jie
State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.
State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.
Anal Chim Acta. 2014 Oct 27;848:10-24. doi: 10.1016/j.aca.2014.08.052. Epub 2014 Aug 29.
β-blockers are the first-line therapeutic agents for treating cardiovascular diseases and also a class of prohibited substances in athletic competitions. In this work, a smart strategy that combines three-way liquid chromatography-mass spectrometry (LC-MS) data with second-order calibration method based on alternating trilinear decomposition (ATLD) algorithm was developed for simultaneous determination of ten β-blockers in human urine and plasma samples. This flexible strategy proved to be a useful tool to solve the problems of overlapped peaks and uncalibrated interferences encountered in quantitative LC-MS, and made the multi-targeted interference-free qualitative and quantitative analysis of β-blockers in complex matrices possible. The limits of detection were in the range of 2.0×10(-5)-6.2×10(-3) μg mL(-1), and the average recoveries were between 90 and 110% with standard deviations and average relative prediction errors less than 10%, indicating that the strategy could provide satisfactory prediction results for ten β-blockers in human urine and plasma samples only using liquid chromatography hyphenated single-quadrupole mass spectrometer in full scan mode. To further confirm the feasibility and reliability of the proposed method, the same batch samples were analyzed by multiple reaction monitoring (MRM) method. T-test demonstrated that there are no significant differences between the prediction results of the two methods. Considering the advantages of fast, low-cost, high sensitivity, and no need of complicated chromatographic and tandem mass spectrometric conditions optimization, the proposed strategy is expected to be extended as an attractive alternative method to quantify analyte(s) of interest in complex systems such as cells, biological fluids, food, environment, pharmaceuticals and other complex samples.
β受体阻滞剂是治疗心血管疾病的一线治疗药物,也是体育比赛中的一类违禁物质。在这项工作中,开发了一种将三元液相色谱-质谱(LC-MS)数据与基于交替三线性分解(ATLD)算法的二阶校准方法相结合的智能策略,用于同时测定人尿液和血浆样品中的十种β受体阻滞剂。这种灵活的策略被证明是解决定量LC-MS中遇到的峰重叠和未校准干扰问题的有用工具,并使复杂基质中β受体阻滞剂的多目标无干扰定性和定量分析成为可能。检测限在2.0×10(-5)-6.2×10(-3) μg mL(-1)范围内,平均回收率在90%至110%之间,标准偏差和平均相对预测误差小于10%,表明该策略仅使用全扫描模式的液相色谱联用单四极杆质谱仪就能为人体尿液和血浆样品中的十种β受体阻滞剂提供令人满意的预测结果。为了进一步证实所提方法的可行性和可靠性,采用多反应监测(MRM)方法对同一批样品进行了分析。t检验表明两种方法的预测结果之间没有显著差异。考虑到该方法具有快速、低成本、高灵敏度且无需复杂的色谱和串联质谱条件优化等优点,预计所提策略将作为一种有吸引力的替代方法扩展应用于对细胞、生物流体、食品、环境、药物等复杂系统中感兴趣的分析物进行定量分析。